Figure 5.
Trafficking of βIV spectrin is not altered in qv3J mice. Double labeling of WT or qv3J optic (A-D) and sciatic (E-H) nerves using βIV NT (N-terminal; A, C, E, G) and Pan Nav (A′, C′, E′, G′) or AnkG (B, D, F, H) and Nav1.6 (B′, D′, F′, H′) antibodies. Double immunostaining of WT (I, I′) and qv3J (J-L) sciatic nerve nodes of Ranvier withβIV NT (I-L) and anti-Caspr antibodies (I′, J′, K′, L′). In qv3J opticnerve, βIVNT immunoreactivity is undetectable. However, in the qv3J PNS, βIVNT was detected in reduced amounts at ∼40% of nodes (G, K, L). AnkyrinG immunoreactivity was detectable in qv3J nodes but reduced in amount and in broader clusters in the CNS (D, arrows). Compared with WT mouse initial segments (M), Nav 1.6 immunoreactivity was reduced at axon initial segments in qv3J mutant mice (N). Scale bars: A-H, 3 μm; I-L, 5 μm; M, N, 10 μm.